Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801
      QxMD      Google Scholar   
Citation:
Blood Adv vol 4 (4) 696-705
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
9
Parents:
2032   2181  
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
Bristol Meyers Squibb  
Grants:
U10CA180821, U10CA180882, P30CA033572, U10CA180833, U10CA180836, U10CA180850, U10CA180866, U10CA180867  
Corr. Author:
 
Authors:
                                   
Networks:
CA043, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL   
Study
CALGB-10801
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-20202
Phases:
2, N/A
Keywords: